Skip to main content
. 2016 Mar 2;7(16):21763–21774. doi: 10.18632/oncotarget.7845

Table 2. Primer pairs and results of the NGS (n/a= not applicable= low DNA quality).

Gene Exon Codon Mutation status Freq. (%) Interpretation
BRAF 11, 15 439-477, 582-620 Wild type
CDK4 2 1-57 Wild type
CDKN2A 1, 2 38-50, 136-152 Case 6 (PDS):
EX1: c148C>T p.Q50* AND
EX2: c.442G>A p.A148T
56.32 22.24 Truncated protein Described, function unknown [52]
GNA11 5 203-245 Wild type
GNAQ 5 203-245 Wild type
HRAS 2, 3, 4 1-37, 38-97, 98-146 Case 6 (PDS):
EX2: c.37G>C p.G13R
19.34 Activating
IDH1 4 89-138 Case 7 (PDS):
EX4: c379C>T p.P127S
18.02 Described, function unknown [53]
KIT 9, 11, 13, 17, 18 450-513, 550-591, 624-659, 784-824, 825-861 Wild type
KNSTRN 1 1-38 Case 6 (PDS):
EX1: c.71C>T p.S24F
29.04 Described [8]
KRAS 2-4 1-37, 41-92, 98-150 Wild type
NRAS 2-4 1-37, 41-92, 98-150 Wild type
OXA1L 1 1-77 Wild type
PDGFRA 12, 14, 18 552-595, 632-667, 814-854 Wild type
PIK3CA 9, 20 514-555, 980-1069 Case 5 (AFX recurring as PDS, both tumors):
EX9: c.1624G>A p.E542K
35.99/48.07 Activating
Case 6 (PDS):
EX9: c.1633G>A p.E545K
36.43 Activating
PTEN 1-7 1-26, 27-55, 56-70, 71-84, 85-164, 165-211, 212-267, 268-342, 343-404 Wild type
RAC1 2 13-35 Wild type
Case 5 (AFX and PDS, both tumors):
EX6: c.672+1G>C AND
EX8: c.818G>A p.R273H
19.19/24.6 36.47/47.68 Splice site base exchange Non-functional proteinneutral
Case 6 (PDS):
EX7: c.697C>T p.H233Y
14.22 neutral
TP53 5-9 126-186, 187-224, 225-261, 262-306, 307-331 Case 7 (PDS):
EX6: c.637C>T p.R213*Case 8 (PDS)
24.98
n/a
Truncated protein
Case 9 (PDS):
EX6: c.585_586CC>>TT p.R196* AND
EX7: c.712T>A p.C238S
36.6
20.53
Truncated protein Non-functional protein
Case 10 (PDS):
EX5: c.490A>T p.K164* AND
EX6: c.586C>T p.R196*
22.56
9.98
Truncated protein
Truncated protein